Literature DB >> 9291893

Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB.

P A Denoel1, T K Vo, V E Weynants, A Tibor, D Gilson, M S Zygmunt, J N Limet, J J Letesson.   

Abstract

Brucellergene is a commercial allergen prepared from Brucella melitensis strain B115 and containing at least 20 cytoplasmic proteins. These proteins were separated by SDS-PAGE. The unstained gel was divided into 18 fractions and proteins were eluted from the gel fractions. The capacity of the separated proteins to elicit delayed-type hypersensitivity (DTH) in infected guinea-pigs or to induce the production of interferon-gamma (IFN-gamma) by blood cells from infected cattle was evaluated. The biological activity of the corresponding protein fractions blotted on to nitrocellulose was measured in a lymphocyte blastogenesis assay. Among the 18 fractions tested, two-spanning the mol. wt ranges 17-22 (fraction 8) and 35-42-kDa (fraction 17)-showed the maximum biological activity in the three tests. These fractions contain two antigens, the Brucella bacterioferritin (BFR) and P39 proteins. Both proteins are good candidates for the detection of cellular immunity to Brucella.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291893     DOI: 10.1099/00222615-46-9-801

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

1.  Iron homeostasis in Brucella abortus: the role of bacterioferritin.

Authors:  Marta A Almirón; Rodolfo A Ugalde
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

2.  Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.

Authors:  R Vemulapalli; S Cravero; C L Calvert; T E Toth; N Sriranganathan; S M Boyle; O L Rossetti; G G Schurig
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godfroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Carlos A Velikovsky; Juliana Cassataro; Guillermo H Giambartolomei; Fernando A Goldbaum; Silvia Estein; Raul A Bowden; Laura Bruno; Carlos A Fossati; Moisés Spitz
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosis.

Authors:  Juliana Cassataro; M Victoria Delpino; Carlos A Velikovsky; Laura Bruno; Carlos A Fossati; Pablo C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

6.  Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.

Authors:  Ayman Al-Mariri; Anne Tibor; Pascal Lestrate; Pascal Mertens; Xavier De Bolle; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Authors:  A Al-Mariri; A Tibor; P Mertens; X De Bolle; P Michel; J Godefroid; K Walravens; J J Letesson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.

Authors:  A Tibor; I Jacques; L Guilloteau; J M Verger; M Grayon; V Wansard; J J Letesson
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 9.  Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Authors:  Jinkyung Ko; Gary A Splitter
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.

Authors:  Carola Muñoz-Montesino; Edilia Andrews; Rodolfo Rivers; Andrés González-Smith; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Angel A Oñate
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.